Silvia Messina
MD
DPhil student
- NMO clinical fellow
- Neurologist
Key publications
-
Clinical presentation and prognosis in MOG-antibody disease: a UK study.
Journal article
Jurynczyk M. et al, (2017), Brain, 140, 3128 - 3138
-
Smoking on disability accumulation in neuromyelitis optica and multiple sclerosis
Conference paper
Messina S. et al, (2017), MULTIPLE SCLEROSIS JOURNAL, 23, 214 - 214
-
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)
Journal article
Messina S. et al, (2017), PLOS ONE, 12, e0180651 - e0180651
-
Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.
Journal article
Hacohen Y. et al, (2018), Mult Scler, 24, 679 - 684
-
Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity
Journal article
Bove R. et al, (2016), Multiple Sclerosis and Related Disorders, 8, 136 - 140
-
Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients
Journal article
Patti F. et al, (2015), PLOS ONE, 10, e0120754 - e0120754
-
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI
Journal article
Messina S. and Patti F., (2014), Multiple Sclerosis International, 2014, 1 - 9
-
Increased leptin and A-FABP levels in relapsing and progressive forms of MS
Journal article
Messina S. et al, (2013), BMC Neurology, 13
-
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment
Journal article
Messina S. and Patti F., (2013), Expert Opinion on Drug Metabolism & Toxicology, 9, 1349 - 1359